CERO — CERo Therapeutics Holdings Balance Sheet
0.000.00%
Last trade - 00:00- $5.88m
- $7.34m
Annual balance sheet for CERo Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 1.1 | 0.476 | 0.097 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 1.36 | 42.4 | 8.56 |
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 180 | 42.4 | 8.56 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.098 | 30.7 | 5.17 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 9.25 | 39.9 | 14.3 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 171 | 2.47 | -5.76 |
| Total Liabilities & Shareholders' Equity | 180 | 42.4 | 8.56 |
| Total Common Shares Outstanding |